ACE2 and infection: However, standard laboratory mice do not support infection with the original USA-WA1/2020 SARS-CoV-2 strain—used in currently available vaccines—due to inefficient interactions between the receptor-binding domain (RBD) of Spike (S) protein and mouse angiotensin-converting enzyme 2 (mACE2) (5, 6).